blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1817058

EP1817058 - COMPOSITION FOR USE IN IMPROVING LIVER CLEARANCE OF XENOBIOTIC SUBSTANCES IN AN ANIMAL [Right-click to bookmark this link]
Former [2007/33]METHODS FOR IMPROVING LIVER CLEARANCE OF XENOBIOTIC SUBSTANCES IN AN ANIMAL
[2013/17]
StatusNo opposition filed within time limit
Status updated on  08.07.2016
Database last updated on 19.07.2024
Most recent event   Tooltip19.10.2018Change - lapse in a contracting statepublished on 21.11.2018  [2018/47]
Applicant(s)For all designated states
Hill's Pet Nutrition, Inc.
400 Southwest 8th Avenue
Topeka, KS 66603 / US
[N/P]
Former [2015/36]For all designated states
Hill's Pet Nutrition, Inc.
400 Southwest 8th Street
Topeka, KS 66603 / US
Former [2007/33]For all designated states
Hill's Pet Nutrition Inc.
400 Southwest 8th Street
Topeka, KS 66603 / US
Inventor(s)01 / ZICKER, Steven, Curtis
3017 Oxford Road
Lawrence, Kansas 66049 / US
02 / PAETAU-ROBINSON, Inke
7530 Sw 69th Street
Auburn, Kansas 66402 / US
 [2007/33]
Representative(s)Daniels, Jeffrey Nicholas, et al
Page White & Farrer Limited
Bedford House
21A John Street
London WC1N 2BF / GB
[N/P]
Former [2015/36]Daniels, Jeffrey Nicholas, et al
Page White & Farrer
Bedford House
John Street
London WC1N 2BF / GB
Former [2007/33]Daniels, Jeffrey Nicholas, et al
Page White & Farrer Bedford House John Street
London, WC1N 2BF / GB
Application number, filing date05852254.123.11.2005
[2007/33]
WO2005US42886
Priority number, dateUS20040630971P24.11.2004         Original published format: US 630971 P
[2007/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006058278
Date:01.06.2006
Language:EN
[2006/22]
Type: A2 Application without search report 
No.:EP1817058
Date:15.08.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 01.06.2006 takes the place of the publication of the European patent application.
[2007/33]
Type: B1 Patent specification 
No.:EP1817058
Date:02.09.2015
Language:EN
[2015/36]
Search report(s)International search report - published on:US01.02.2007
(Supplementary) European search report - dispatched on:EP12.06.2012
ClassificationIPC:A61K47/00, A23K1/16, A23K1/18
[2012/27]
CPC:
A61K31/385 (EP,US); A23K20/121 (EP,US); A23K20/158 (EP,US);
A23K50/40 (EP,US); A23K50/42 (EP,US); A61P1/00 (EP);
A61P1/16 (EP) (-)
Former IPC [2007/33]A61K47/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/36]
Former [2007/33]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZUSAMMENSETZUNG ZUR VERWENDUNG DER VERBESSERUNG DER BESEITIGUNG VON XENOBIOTISCHEN SUBSTANZEN AUS DER LEBER BEI EINEM TIER[2013/17]
English:COMPOSITION FOR USE IN IMPROVING LIVER CLEARANCE OF XENOBIOTIC SUBSTANCES IN AN ANIMAL[2013/17]
French:COMPOSITION DESTINEE A ETRE UTILISEE POUR FACILITER LE DECHARGEMENT DU FOIE D'UN ANIMAL DES SUBSTANCES XENOBIOTIQUES[2013/17]
Former [2007/33]VERFAHREN ZUR VERBESSERUNG DER BESEITIGUNG VON XENOBIOTISCHEN SUBSTANZEN AUS DER LEBER BEI EINEM TIER
Former [2007/33]METHODS FOR IMPROVING LIVER CLEARANCE OF XENOBIOTIC SUBSTANCES IN AN ANIMAL
Former [2007/33]PROCEDES DESTINES A FACILITER LE DECHARGEMENT DU FOIE D'UN ANIMAL DES SUBSTANCES XENOBIOTIQUES
Entry into regional phase29.05.2007National basic fee paid 
29.05.2007Search fee paid 
29.05.2007Designation fee(s) paid 
29.05.2007Examination fee paid 
Examination procedure29.05.2007Examination requested  [2007/33]
21.09.2012Amendment by applicant (claims and/or description)
27.11.2012Despatch of a communication from the examining division (Time limit: M04)
08.03.2013Reply to a communication from the examining division
05.04.2013Despatch of a communication from the examining division (Time limit: M04)
31.07.2013Reply to a communication from the examining division
16.03.2015Communication of intention to grant the patent
27.07.2015Fee for grant paid
27.07.2015Fee for publishing/printing paid
27.07.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.11.2012
Opposition(s)03.06.2016No opposition filed within time limit [2016/32]
Fees paidRenewal fee
06.11.2007Renewal fee patent year 03
07.11.2008Renewal fee patent year 04
06.11.2009Renewal fee patent year 05
22.10.2010Renewal fee patent year 06
07.11.2011Renewal fee patent year 07
07.11.2012Renewal fee patent year 08
07.11.2013Renewal fee patent year 09
07.11.2014Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.11.2005
AT02.09.2015
BG02.09.2015
CY02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
TR02.09.2015
IE23.11.2015
LU23.11.2015
CH30.11.2015
LI30.11.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
[2018/47]
Former [2017/39]HU23.11.2005
AT02.09.2015
BG02.09.2015
CY02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
TR02.09.2015
IE23.11.2015
LU23.11.2015
CH30.11.2015
LI30.11.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2017/37]HU23.11.2005
AT02.09.2015
BG02.09.2015
CY02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
IE23.11.2015
LU23.11.2015
CH30.11.2015
LI30.11.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2017/13]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
IE23.11.2015
IT23.11.2015
LU23.11.2015
CH30.11.2015
LI30.11.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/45]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
IE23.11.2015
LU23.11.2015
CH30.11.2015
LI30.11.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/36]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
LU23.11.2015
CH30.11.2015
LI30.11.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/33]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SK02.09.2015
LU23.11.2015
CH30.11.2015
LI30.11.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/31]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SK02.09.2015
LU23.11.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/28]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/24]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/23]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
Former [2016/22]AT02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
PL02.09.2015
SE02.09.2015
GR03.12.2015
IS02.01.2016
Former [2016/11]AT02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
PL02.09.2015
SE02.09.2015
GR03.12.2015
Former [2016/10]FI02.09.2015
LT02.09.2015
LV02.09.2015
PL02.09.2015
SE02.09.2015
GR03.12.2015
Former [2016/09]FI02.09.2015
LT02.09.2015
LV02.09.2015
GR03.12.2015
Former [2016/07]LT02.09.2015
Documents cited:Search[X]US2002006907  (GARDINER PAUL [CA], et al) [X] 16-20 * claims 8, 16 *;
 [XDY]US2002076469  (ZICKER STEVEN CURTIS [US], et al) [XD] 16-20 * example 1; claims 1, 2, 8 * [Y] 1-15,21;
 [X]US2003224061  (PACIORETTY LINDA M [US], et al) [X] 16 * claims 1, 2 *;
 [Y]  - Beth M. Ley, "Alpha Lipoic Acid", (20000614), URL: http://web.archive.org/web/20000614235007/http://www.tldp.com/issue/160/160alpha.htm, (20120525), XP002676684 [Y] 1-15,21 * paragraphs [0008] , [ 0013] *
 [A]  - BERKSON B M, "A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories", MEDLINE,, (19991015), XP002567154 [A] 1-21 * the whole document *
International search[Y]US5624896  (AXWORTHY DONALD B [US], et al);
 [X]US2002076469  (ZICKER STEVEN CURTIS [US], et al);
 [X]US6914071  (ZICKER STEVEN CURTIS [US], et al)
by applicantUS2002006907
 US2003224061
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.